èªç¶çã«ååšããªã人工ããã±ã質ããæ©æ¢°åŠç¿æè¡ãçšããŠãã¶ã€ã³ããããšã§ãæ°ããªæäœãé µçŽ ãªã©ã®æ²»çè¬ãäœãåºãããšãç®æããã€ãªãã³ãã£ãŒ
ããŒã ããŒãžïŒhttps://generatebiomedicines.com/
èæ¯ãšãã¯ãããžãŒïŒ
ã»æ žããã±ã質ãèããã±ã質ããã ããã±ã質ããªãããã±ã質ãç±ã·ã§ãã¯ããã±ã質ãåçž®ããã±ã質ãªã©ãå€çš®å€æ§ãªå€©ç¶ããã±ã質ã¯ã極ããŠé«ãå¹çãçµæžæ§ã粟å¯ãªåäœãåææã®èªå·±çµç¹åãªã©ã人工æ©æ¢°ãšæ¯èŒããŠé©ãã»ã©åªããç¹æ§ã瀺ããŠããããã®èšå€§ãªéãšçŽ æŽãããå質ããããŠå€èœæ§ãèæ ®ãããšãããã±ã質ææã¯ãå€ãã®æ·±å»ãªç€ŸäŒç課é¡ã«å¯Ÿãã解決çãæäŸã§ããå¯èœæ§ãããããã倧ããªæ³šç®ãéããŠããã
ã»ãããããã€ãã£ããªããã±ã質ã¯ã䜿çšç°å¢ãå³ããå¶éããã寿åœãæ¯èŒççãããã人éã®æºçãªèŠæ±ã«ååã«å¿ããããšã¯ã§ããªãããŸãã倩ç¶ããã±ã質ã¯æ°çŸäžå¹Žã®é²åãçµãŠãèªç¶ã®éžæå§ã®ããšã§åŸã ã«æé©åãããŠãããã®ã§ãããããæ°çŸå¹Žä»¥å ã«äººé瀟äŒã§çãã課é¡ã«å¯Ÿå¿ã§ããå¯èœæ§ã¯åççã«äœããããã§ã人工çã«ããã±ã質ãæ¹å€ããããã«äžæ©é²ãã§ããŒãããæ°ããããã±ã質ããã¶ã€ã³ããããšããæ代ã®èŠè«ãšããŠæµ®äžããŠããã幞ããªããšã«ããããŸã§ã®ããã±ã質ã®çååŠçãçç©ç©çåŠçç 究ã®èç©ã«ãããããã±ã質èšèšãæè¡çã«å¯èœã«ãªã£ãŠããŠããã
ã»åŸæ¥ã®ããã±ã質ã®ç«äœæ§é äºæž¬ããã°ã©ã ã¯ãããããã®é·ããé·ããªãã«ã€ããŠïŒç¹ã«ããããã®é·ãã20æ®åºä»¥äžã®å ŽåïŒãã¢ã«ãŽãªãºã ã®æ§èœã¯äœäžãããããããäžæ¬¡ããã±ã質é åããŒã¿ã®ã¿ãå ¥åãšããŠäžããã³ã³ãã¥ãŒã¿ãŒããã°ã©ã AlphaFoldãããã®é åãæãç³ãŸããäžæ¬¡å é 眮ã決å®ããéã®å®éšç²ŸåºŠãšã»ãŒäžèŽãããšçºè¡šããŠãããAlphaFoldã¯çãããããã ãã§ãªããæ°çŸã¢ããé žã®é·ãã®ããã±ã質é åããããã±ã質ã®æãç³ãŸããäžæ¬¡å é 眮ãããã®ç²ŸåºŠã§äºæž¬å¯èœã§ããã
ã»ããããéæ£èŠã¢ããé žïŒå€©ç¶ã«ååšããªãã¢ããé žãå«ãïŒãæ§æããããã±ã質ã«é¢ããŠã¯ãAlphaFoldã¯ä»ã®ãã³ãã¬ãŒãããŒã¹ã®ã¢ãããŒããšåæ§ã«ãçç©é²åã«ãã£ãŠçæãããããã±ã質ã®ãµãã»ããããåŠç¿ããŠäºæž¬ãè¡ããããããŸã圹ã«ç«ããªããé åãšæ§é ã®é¢ä¿ã®ããã©ã€ãã©ãªã§ãã¬ãŒãã³ã°ãããæ©æ¢°åŠç¿ã¯ããã®ã©ã€ãã©ãªå ã®ãã®ããããé¢ããé åãŸã§äºæž¬ãæ¡åŒµããããšã¯ã§ããªããçžåæ§ã«åºã¥ããã³ãã¬ãŒãã¢ããªã³ã°ã®éçã¯ãããã±ã質ãã©ãŒã«ã空éã®ãæé»ç©è³ªããæ±ã人ã ã«ãšã£ãŠããã§ã«çŸå®ã®ãã®ãšãªã£ãŠããã
ã»äžæ¹ã§ããã®éåé¡ãã€ãŸããç¹å®ã®åœ¢ã«æãç³ãŸããæ®åºã®é åãã©ã®ããã«èšèšããããšããåé¡ãããããã®åé¡ã解決ãããããGANïŒGenerative Adversarial NetworksïŒãªã©ã®çæã¢ãã«ãçšããŠãæ°ããããã¯ããŒã³ãèšèšããããšãè©Šã¿ãããŠãããGANã¯ãæ¢ç¥ã®ããã±ã質ã®ããã¯ããŒã³ãçšããŠãèªç¶çã«ååšããªã圢ç¶ã®ããã¯ããŒã³ãçæããããšãè©Šã¿ãããŸããéããã±ã質æãããã¿åé¡ã«å¯Ÿããææ³ãšããŠãçŸåšæå 端ã®æ§èœãçºæ®ããŠããTIMEDïŒThree-dimensional Inference Method for Efficient DesignïŒãæ¹è¯ããããšãè©Šã¿ãããŠããã
ã»ãã®2ã€ã®åé¡ã«æåããã°ãde novoããã±ã質ã®èšèšã«å¿ èŠãªãã¹ãŠã®ããŒã«ãæã«å ¥ããããšãã§ããããããŠããã®æ¹æ³ãçšããŠã觊åªå¹çã®åäžãå®å®æ§ã®åäžãªã©ãç¹å®ã®çšéã念é ã«çœ®ããããã±ã質ã®èšèšãåèšèšãè¡ãããšãã§ããããã«ãªãããšãæåŸ ãããã
ã»ä»å玹ä»ããGenerate Biomedicinesã¯ãæ©æ¢°åŠç¿ã¢ã«ãŽãªãºã ã«ãã£ãŠãèªç¶çã§ã¯èŠãããšããªããããªããã±ã質ã®æ°ããé åãçæããããšã§ããŸã£ããæ°ããããã±ã質ãæ²»çæ³ãçã¿åºããç æ°ã®æ²»çãè€éãªçç©åŠç課é¡ã®è§£æ±ºãç®æããã€ãªãã³ãã£ãŒã§ããã
ã»Generate Biomedicinesã®æ©æ¢°åŠç¿ã¢ã«ãŽãªãºã ã¯ãäœåãã®æ¢ç¥ã®ããã±ã質ãåæããã¢ããé žé åãæ§é ãæ©èœãçµã³ã€ããçµ±èšçãã¿ãŒã³ãæ¢ãããã®çµ±èšçãã¿ãŒã³ãå©çšããŠãçãããããããè€éãªæäœãé µçŽ ãéºäŒåæ²»çè¬ããããŠãŸã 解æãããŠããªãããã±ã質çµæç©ã«è³ããŸã§ãã«ã¹ã¿ã ããã±ã質治çè¬ãçæããŠããã
ã»æè¡ã®è©³çŽ°ã¯æªé瀺ãã¢ãã¯ããŒãã«æäœããã€ã¹ãã·ãã£ãã¯ã现èçæ³ãªã©ãã¢ããªãã£ã«ãšããããªãã¢ãããŒããè¡ã£ãŠãããèªç€Ÿã§è£œé ããã¿ã³ãã¯è³ªã®æ§é ã決å®ããããã«ã¯ã©ã€ãªé»åé¡åŸ®é¡ã«æè³ãããã®ããŒã¿ãèªç€Ÿã®ãã©ãããã©ãŒã ã«ãã£ãŒãããã¯ããŠæ§èœãåäžãããããšãç®æããŠããã
ãã€ãã©ã€ã³ïŒæªé瀺
éç¹é åã¯ããããå ç«ãææçã瀟å ãã€ãã©ã€ã³ã¯ãæšå¹Žæ«ã«ãªãã¯ãã³ãåºçŸãããšãã«çæããSARS-CoV-2ã®ã¹ãã€ã¯ããã±ã質ã®ä¿åé åã«å¯Ÿããåºç¯ãªäžåæäœã®ç 究ãäžå¿ã«ãªã£ãŠããããã¹ãŠã®SARS-CoVãŠã€ã«ã¹ã«é«åºŠã«ä¿åãããŠããS2ãã¡ã€ã³ã®äžåå€ãèŠåºããŠãããæ¥å¹ŽåããŸã§ã«FDAã«èšåºè©Šéšã®éå§ãç³è«ã§ããããšãæåŸ ãããã
æè¿ã®ãã¥ãŒã¹ïŒ
è€æ°ã®æ²»çé åãšè€æ°ã®æ²»çæ³ã«ããã5ã€ã®èšåºæšçã«å¯Ÿããããã±ã質治çè¬ã®çºèŠãšåµåºã«é¢ããå ±åç 究å¥çŽãAmgenãšç· çµ
ã³ã¡ã³ãïŒ
ã»Modernaã®åµæ¥ãäž»å°ããFlagship Pioneeringã®ããŒãããŒCEOã§ããMike NallyãGenerate Biomedicinesã®CEOãåããŠããã
ã»ãµã€ãã«ã€ã³ã®äžã«ã¯åŒ·ãå ç«èª¿ç¯äœçšãæã€ãã®ãå ±åãããŠãããããã®å€ãã¯è€æ°ã®ã·ã°ãã«ãæµããŠããŸãããã«å¯äœçšãåé¡ãšãªã£ãŠãããGenerate Biomedicinesã®ãããªåæçç©åŠçã¢ãããŒãã§ãæçãªã·ã°ãã«ã ããèªå°ãã人工ãµã€ãã«ã€ã³ãªã©ã®éçºãé²ããããŠãããæ©æ¢°åŠç¿æè¡ãçšãã人工ããã±ã質ãã¶ã€ã³ã¯ç¥èŠãéãŸãã»ã©æå確çãäžãã£ãŠããå¯èœæ§ãé«ãããããéåžžã«åŒ·åãªãã©ãããã©ãŒã æè¡ã«ãªããããããªãã
ããŒã¯ãŒãïŒ
ã»de novoããã±ã質
ã»åæçç©åŠ
ã»äººå·¥ç¥èœïŒAIïŒåµè¬
ã»ææç
ã»å ç«
å 責äºé ïŒ
æ£ç¢ºãªæ å ±æäŸãå¿ãããŠããŸãããæ¬å 容ã«åºã¥ããåŠäœãªãã¢ã¯ã·ã§ã³ã«å¯ŸããŠãã±ã³ã¯è²¬ä»»ããšããŸããããããããé¡ãããŸãã